Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

FDA Transparency Hits a Roadblock; Why Drug Rejection Letters Suddenly Stopped

The U.S. Food and Drug Administration (FDA) has temporarily paused the public release of Complete Response Letters (CRLs). The agency made the decision after an unnamed pharmaceutical company challenged the policy over confidentiality concerns. The move temporarily suspends one of
  • News
FDA Transparency Hits a Roadblock; Why Drug Rejection Letters Suddenly Stopped

ConcertAI Expands CancerLinQ; Trust in Clinical AI Now Depends on Validation

ConcertAI has expanded its CancerLinQ platform beyond quality reporting into an AI-powered clinical decision support system that integrates trial matching, structured data extraction, and real-time oncology insights. The announcement highlights a broader industry shift: as AI becomes part of clinical
  • News
ConcertAI Expands CancerLinQ; Trust in Clinical AI Now Depends on Validation

AI Agents Enter Regulated Workflows; Penn Medicine Starts a New Healthcare Shift

Penn Medicine has integrated K Health’s AI-powered patient intake agents into its virtual primary care service, marking another step toward embedding AI agents into regulated clinical workflows. Rather than replacing clinicians, the system gathers patient information before appointments and delivers
  • News
AI Agents Enter Regulated Workflows; Penn Medicine Starts a New Healthcare Shift